What we do Genpharmasec Ltd operates in pharmaceuticals, specializing in diagnostic equipment distribution, laboratory testing, and equity trading, with a focus on medical diagnostics and healthcare solutions. |
Founded in 1,992 |
Market share Growing presence in Indian diagnostic pharma equipment distribution with expanding subsidiaries in India and Dubai. |
Problem solved Provides quick diagnostic tools and laboratory services addressing urgent medical testing needs, improving healthcare responsiveness. |
Top clients or who we serve Hospitals, healthcare providers, and diagnostic centers; primarily B2B. |
Key management - |
Our journey and innovations Started in chemicals, pivoted to pharmaceuticals and diagnostics in 2018; partnered with Abbott Point of Care USA; expanded with clinical labs and acquisitions. |
Where we operate India and Dubai, UAE with plans for broader Indian market penetration. |
Top products or what we offer Diagnostic equipment distribution including Abbott's i-STAT analyzers, laboratory testing services, and equity trading. |
Top brands i-STAT 1 Analyzer - exclusive blood analyzer widely used in ICUs across India; Clinigenome clinical labs expanding diagnostics footprint. |
Raw materials needed - |
Raw materials supplier Abbott Point of Care, USA (importer of diagnostic cartridges and analyzers) |
Recurring vs cyclical contribution Revenue mix includes recurring diagnostics equipment sales and lab services; equity trading is non-recurring. |
Our industry position Emerging player in diagnostic equipment distribution with exclusive partnerships and growing lab services presence. |
Financial highlights FY 2024-25 consolidated revenue Rs 33.72 crore, profit after tax Rs 1.23 crore, showing steady growth and improved profitability. |
Geographical revenue split Primarily Indian revenue with subsidiary operations in Dubai; majority from diagnostic equipment and services. |
Order book - |
Whats driving growth Exclusive Abbott partnerships, import of consumables, expansion into diagnostic labs, and recent healthcare acquisitions. |
Our future plans Expand clinical laboratories, increase distribution reach across India, and integrate healthcare acquisitions for growth. |
Our green promise - |
Our people and values Committed employee base focusing on ethical governance, transparency, and adherence to compliance standards. |
Key challenges ahead Dependence on single supplier risks, competitive diagnostic market, and scaling operational footprint efficiently. |
Interesting facts Partnered with Abbott USA for exclusive distribution; formed subsidiaries domestically and internationally for diagnostics. |
Risks and strategy Mitigating supplier dependency by expanding product range and geographic presence; enhancing internal controls and compliance. |
